IMPROVING ACCESS TO DIAGNOSIS, TREAMENT AND CARE
FOR PATIENTS WITH RARE DISEASES
The RDAF brings together experts from patient and research organizations, industry and healthcare professionals active in the rare disease field in Switzerland.
Patient organizations
Industry
Novartis Gene Therapies
Healthcare professionals and research organizations
Forschungszentrum für das Kind, Universitätskinderspital Zürich – Eleonorenstiftung
Prof. Dr. med. Philipp Latzin
Prof. Dr. Pascal Escher
Prof. Andrea Superti-Furga, Service de Médecine Génétique – CHUV